Ongoing research on CD61 focuses on understanding its role in disease mechanisms and developing therapeutic strategies. Researchers are investigating how CD61-mediated signaling pathways contribute to cancer progression and resistance to therapies. Additionally, novel therapeutic agents targeting CD61 are being explored for their potential to inhibit tumor growth and metastasis.
